2017
Influence of Prescribed Blood Products on the Incidence of Deep Vein Thrombosis and Pulmonary Embolism in Surgical Patients
MARUSIC, A.P., I. LOCATELLI, A. MRHAR, M. CAPRNDA, L. GASPAR et. al.Základní údaje
Originální název
Influence of Prescribed Blood Products on the Incidence of Deep Vein Thrombosis and Pulmonary Embolism in Surgical Patients
Autoři
MARUSIC, A.P. (705 Slovinsko), I. LOCATELLI (705 Slovinsko), A. MRHAR (705 Slovinsko), M. CAPRNDA (703 Slovensko), L. GASPAR (705 Slovinsko), M. ADAMEK (616 Polsko), Peter KRUŽLIAK (703 Slovensko, garant, domácí) a D. PETROVIC (705 Slovinsko)
Vydání
Clinical and Applied Thrombosis-Hemostasis, Thousand Oaks, Sage Publications Inc. 2017, 1076-0296
Další údaje
Jazyk
angličtina
Typ výsledku
Článek v odborném periodiku
Obor
30205 Hematology
Stát vydavatele
Spojené státy
Utajení
není předmětem státního či obchodního tajemství
Impakt faktor
Impact factor: 1.852
Kód RIV
RIV/00216224:14110/17:00099909
Organizační jednotka
Lékařská fakulta
UT WoS
000412901900006
Klíčová slova anglicky
prevention of venous thromboembolism; red blood cells; vitamin K; blood replacement
Štítky
Příznaky
Mezinárodní význam, Recenzováno
Změněno: 20. 3. 2018 15:27, Soňa Böhmová
Anotace
V originále
Deep vein thrombosis (DVT) and pulmonary embolisms (PEs) are common complications after surgical procedures. The influence of prescribed blood products on the occurrence of DVT and PE was evaluated in postsurgical patients in this retrospective case-control study. The records of 286 surgical patients were analyzed: DVT (n = 52), PE (n = 92), and a control group (n = 142). The amounts of prescribed blood, blood products, and vitamin K were reviewed, together with appropriate prescribing of low-molecular-weight heparins. The influence of prescribed blood products on the occurrence of DVT or PE was analyzed using multinomial logistic regression. We demonstrated a significant difference between the test and control groups (P < .05) in relation to receiving packed red blood cells. Treatment with red blood cells was associated with an increased risk of PE but not DVT. Patients who developed PE after surgery were hospitalized for longer (median 10 days) than patients with DVT (median 6 days). There was no difference between the test and control groups concerning treatment with fresh frozen plasma. Inadequate thromboprophylaxis significantly increased the likelihood of DVT. There is a connection between receiving packed red blood cells and occurrence of postoperative PE in surgical patients. Thus, patients receiving red blood cells should be monitored more closely after surgery, as they are more likely to develop PE postoperatively.